The most neglected diseases of the world are mainly those that are hard to treat with standardized drugs. They are often neglected because there are so many variants of the disease. While one drug may do well in one part of the world, the same drug will be ineffective in another part of the world.
These neglected diseases are Malaria, Tuberculosis, and Dengue Fever. We associate these diseases with poor or lesser-developed countries in tropical latitudes. We often ignore the fact that these diseases affect a growing number of people in ‘developed’ countries.
Developing effective drug treatments for these diseases that primarily affect poorer countries are often seen by large drug companies and their research arms to be ‘bad risk’ drugs that will hurt the company’s bottom line profit targets.
As such, they are neglected and the millions of people living in affected areas must continue to suffer with these diseases.
There is some good news on the horizon however and there are products already available that could practically eliminate these neglected diseases.
Read on to discover what they are.
Sandwalker
Top Wellness Products
It seems a few Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called “neglected” diseases that claim millions of lives in the developing world each year. Those hard-to-treat diseases include malaria, tuberculosis, dengue fever, and other conditions. That’s the topic of the cover story scheduled for the current issue of Chemical & Engineering News, ACS’ weekly newsmagazine.
C&EN Senior Editor Lisa Jarvis explains that just a decade ago major pharmaceutical companies had largely abandoned developing treatments for these neglected diseases. But as the need for new drugs became increasingly apparent, they did an about-face. Malaria and tuberculosis each cause more than 1 million deaths each year. Dengue fever, a mosquito-borne infection, causes hundreds of thousands of deaths each year and its rate of infection is rising dramatically. A growing number of scientists are concerned that global warming will translate into explosive growth in these and other tropical diseases.
The article describes how public-private partnerships between drug companies, nonprofits, and philanthropists are springing up to address this problem, particularly the wide gap between drug need and availability. But challenges remain, including who will pay for the drugs and how they will be distributed to patients in remote areas. Even though drug companies can expect to profit little from these ventures, a growing number see it as good business and are excited about a steady stream of new drug candidates, the article notes.
Nutronix International, a health and wellness product distribution company located in Mechanicsville, VA works closely as a licensee of American Biotech Labs in Alpine, Utah. ABL works tirelessly to develop their patented Silver Sol Technology into products that have been tested for years in countries in Africa and Asia.
One such product is the 14ppm New Silver Solution. Another is the 24ppm New Silver Solution Gel. These products are exclusively licensed to Nutronix International. Nutronix currently has a program in which distributors can donate a bottle of the New Silver Solution for Malaria sufferers in Africa. Previous clinical studies demonstrated that even a 10ppm silver sol product can kill Malaria in humans even at advanced final stages of the disease.
You can learn more about it by clicking on Silver Sol. For those who would like a more thorough presentation, you can click on Dr Gordon Pedersen and watch his excellent webinar on how this product kills pathogens it encounters in the human body. If you are interested in a six-minute summary of what the New Silver Solution can do for you and why you should have it in your home, you can click on Silver Sol Technology Opportunity
Click New Silver Solution Gel to learn more.
Click Something Here to Pass It On:
November 18th, 2009 | Tags: Acs, Bad Risk, Bottom Line Profit, Business, C Amp, Chemical & Engineering News, Clinical trial, Conditions and Diseases, Developing country, Developing World, Engineering News, Hard To Treat Diseases, Health, Infectious Disease, Jarvis, Malaria, Mosquito, New Drugs, Newsmagazine, Nonprofit Organizations, Pharmaceutical Companies, Pharmaceutical industry, Profit Targets, Tropical Latitudes, Tuberculosis, Vaccines, Wellness Products, World Each Year | Category: Diseases And Conditions, HIV/AIDS in Africa, Health, Infectious Diseases, Silver Solution For Flu | Leave a comment
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=60e58da6-bf39-4c1c-8cc7-966739447f89 "The Most Neglected Diseases of the World")
